Article
Clinical Characteristics of Pathogenic ACAN Variants and 3-Year Response to Growth Hormone Treatment: Real-World Data.
Hormone research in paediatrics - 1 Jan 2024
Renes Judith S, Reedijk Ardine M J, Losekoot Monique, Kant Sarina G, Van der Steen Manouk, Van der Kaay Danielle C M, Hokken-Koelega Anita C S, Van Duyvenvoorde Hermine A, de Bruin Christiaan
Abstract excerpt
INTRODUCTION: Heterozygous variants in the ACAN gene may underlie disproportionate short stature with characteristically accelerated bone age (BA) maturation and/or early-onset osteoarthritis (OA). METHODS: The objective of this study was to describe phenotype, analyze genotype-phenotype correlations, and assess the response of growth hormone (GH) treatment in children with a heterozygous ACAN variant. Thirty-six...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
